Weissella bacteria-derived nanovesicle and use thereof
AssigneeMd Healthcare Inc.
InventorYoon-Keun KIM
Life of this patent
Estimating the term…
Abstract
Provided are vesicles derived from bacteria of the genus Weissella and a use thereof. The present inventors experimentally identified that vesicles derived from bacteria of the genus Weissella effectively suppress the secretion of inflammatory mediators from pathogenic vesicles inducing inflammation. Thus, it is expected that the vesicles derived from bacteria of the genus Weissella according to the presently claimed subject matter will be advantageously used for the purpose of developing a composition for preventing, alleviating, or treating inflammatory diseases.
Claims7
A method of alleviating or treating an inflammatory disease, the method comprising administering to a subject in need thereof a composition comprising an effective amount of vesicles derived from bacteria of the genus Weissella.
-15. (canceled)
Dependencies are inferred from the claim text.